IBBQ vs. PBE: Which Biotech ETF Is the Better Buy?
PBE concentrates on 31 companies and offers a higher dividend yield, while IBBQ spreads risk across 251 holdings at a fraction of the cost.
Overview
Investors looking for exposure to biotech have two very different options from the same fund family. The Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) spreads its bets across 251 companies and charges low fees, while the Invesco Biotechnology & Genome ETF (NYSEMKT:PBE) takes a concentrated, quant-driven approach with just 31 holdings and offers a higher dividend yield.
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Details
IBBQ is the cheaper option, with 0.19% expense ratio compared to 0.58% for PBE. However, income seekers may prefer PBE's higher 1.73% dividend yield, which is more than twice IBBQ's 0.80% yield.
Source
Originally published at www.fool.com.